328 related articles for article (PubMed ID: 19252524)
1. miR-449a targets HDAC-1 and induces growth arrest in prostate cancer.
Noonan EJ; Place RF; Pookot D; Basak S; Whitson JM; Hirata H; Giardina C; Dahiya R
Oncogene; 2009 Apr; 28(14):1714-24. PubMed ID: 19252524
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells.
Li T; Li D; Sha J; Sun P; Huang Y
Biochem Biophys Res Commun; 2009 Jun; 383(3):280-5. PubMed ID: 19302977
[TBL] [Abstract][Full Text] [Related]
3. Screening of histone deacetylases (HDAC) expression in human prostate cancer reveals distinct class I HDAC profiles between epithelial and stromal cells.
Waltregny D; North B; Van Mellaert F; de Leval J; Verdin E; Castronovo V
Eur J Histochem; 2004; 48(3):273-90. PubMed ID: 15590418
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation.
Lee KH; Chen YL; Yeh SD; Hsiao M; Lin JT; Goan YG; Lu PJ
Oncogene; 2009 Sep; 28(38):3360-70. PubMed ID: 19597470
[TBL] [Abstract][Full Text] [Related]
5. Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells.
Fujita Y; Kojima K; Hamada N; Ohhashi R; Akao Y; Nozawa Y; Deguchi T; Ito M
Biochem Biophys Res Commun; 2008 Dec; 377(1):114-9. PubMed ID: 18834855
[TBL] [Abstract][Full Text] [Related]
6. miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon.
Gandellini P; Folini M; Longoni N; Pennati M; Binda M; Colecchia M; Salvioni R; Supino R; Moretti R; Limonta P; Valdagni R; Daidone MG; Zaffaroni N
Cancer Res; 2009 Mar; 69(6):2287-95. PubMed ID: 19244118
[TBL] [Abstract][Full Text] [Related]
7. miR-200bc/429 cluster targets PLCgamma1 and differentially regulates proliferation and EGF-driven invasion than miR-200a/141 in breast cancer.
Uhlmann S; Zhang JD; Schwäger A; Mannsperger H; Riazalhosseini Y; Burmester S; Ward A; Korf U; Wiemann S; Sahin O
Oncogene; 2010 Jul; 29(30):4297-306. PubMed ID: 20514023
[TBL] [Abstract][Full Text] [Related]
8. miR-145 inhibits breast cancer cell growth through RTKN.
Wang S; Bian C; Yang Z; Bo Y; Li J; Zeng L; Zhou H; Zhao RC
Int J Oncol; 2009 May; 34(5):1461-6. PubMed ID: 19360360
[TBL] [Abstract][Full Text] [Related]
9. miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells.
Noonan EJ; Place RF; Basak S; Pookot D; Li LC
Oncotarget; 2010 Sep; 1(5):349-58. PubMed ID: 20948989
[TBL] [Abstract][Full Text] [Related]
10. E2F1-inducible microRNA 449a/b suppresses cell proliferation and promotes apoptosis.
Lizé M; Pilarski S; Dobbelstein M
Cell Death Differ; 2010 Mar; 17(3):452-8. PubMed ID: 19960022
[TBL] [Abstract][Full Text] [Related]
11. Expression profile of class I histone deacetylases in human cancer tissues.
Nakagawa M; Oda Y; Eguchi T; Aishima S; Yao T; Hosoi F; Basaki Y; Ono M; Kuwano M; Tanaka M; Tsuneyoshi M
Oncol Rep; 2007 Oct; 18(4):769-74. PubMed ID: 17786334
[TBL] [Abstract][Full Text] [Related]
12. Restoration of miR-145 expression suppresses cell proliferation, migration and invasion in prostate cancer by targeting FSCN1.
Fuse M; Nohata N; Kojima S; Sakamoto S; Chiyomaru T; Kawakami K; Enokida H; Nakagawa M; Naya Y; Ichikawa T; Seki N
Int J Oncol; 2011 Apr; 38(4):1093-101. PubMed ID: 21258769
[TBL] [Abstract][Full Text] [Related]
13. The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities.
Bonci D; Coppola V; Musumeci M; Addario A; Giuffrida R; Memeo L; D'Urso L; Pagliuca A; Biffoni M; Labbaye C; Bartucci M; Muto G; Peschle C; De Maria R
Nat Med; 2008 Nov; 14(11):1271-7. PubMed ID: 18931683
[TBL] [Abstract][Full Text] [Related]
14. miR-34b targets cyclic AMP-responsive element binding protein in acute myeloid leukemia.
Pigazzi M; Manara E; Baron E; Basso G
Cancer Res; 2009 Mar; 69(6):2471-8. PubMed ID: 19258499
[TBL] [Abstract][Full Text] [Related]
15. MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma.
Fornari F; Gramantieri L; Ferracin M; Veronese A; Sabbioni S; Calin GA; Grazi GL; Giovannini C; Croce CM; Bolondi L; Negrini M
Oncogene; 2008 Sep; 27(43):5651-61. PubMed ID: 18521080
[TBL] [Abstract][Full Text] [Related]
16. Involvement of HDAC1 in E-cadherin expression in prostate cancer cells; its implication for cell motility and invasion.
Kim NH; Kim SN; Kim YK
Biochem Biophys Res Commun; 2011 Jan; 404(4):915-21. PubMed ID: 21184735
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kappaB1.
Guo LM; Pu Y; Han Z; Liu T; Li YX; Liu M; Li X; Tang H
FEBS J; 2009 Oct; 276(19):5537-46. PubMed ID: 19702828
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic mechanism of growth inhibition induced by phenylhexyl isothiocyanate in prostate cancer cells.
Beklemisheva AA; Fang Y; Feng J; Ma X; Dai W; Chiao JW
Anticancer Res; 2006; 26(2A):1225-30. PubMed ID: 16619528
[TBL] [Abstract][Full Text] [Related]
19. microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells.
Bandres E; Bitarte N; Arias F; Agorreta J; Fortes P; Agirre X; Zarate R; Diaz-Gonzalez JA; Ramirez N; Sola JJ; Jimenez P; Rodriguez J; Garcia-Foncillas J
Clin Cancer Res; 2009 Apr; 15(7):2281-90. PubMed ID: 19318487
[TBL] [Abstract][Full Text] [Related]
20. Endogenous inhibition of histone deacetylase 1 by tumor-suppressive maspin.
Li X; Yin S; Meng Y; Sakr W; Sheng S
Cancer Res; 2006 Sep; 66(18):9323-9. PubMed ID: 16982778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
